Effect of formulation composition on the properties of controlled release tablets prepared by roller compaction

Drug Development and Industrial Pharmacy

Volumn 30, Issue 6, 2004, Pages 565-572

  Hariharan, Madhusudan ^a,b   Wowchuk, Christina ^a   Nkansah, Paul ^a   Gupta, Vishal K ^a,c  

^a PFIZER INC   (United States)

^b ABBOTT LABORATORIES   (United States)

^c Tyco Healthcare   (United States)

Author keywords

Controlled release; Diclofenac; Glyceryl behenate; Hydroxypropyl methylcellulose; Microcrystalline cellulose; Roller compaction; Sustained release; Tablets

Indexed keywords

DICLOFENAC; GLYCEROL BEHENATE; HYDROXYPROPYLMETHYLCELLULOSE; MICROCRYSTALLINE CELLULOSE;

ARTICLE; DRUG SOLUBILITY; PARTICLE SIZE; PHARMACEUTICAL ENGINEERING; SUSTAINED DRUG RELEASE; TABLET COMPRESSION; TABLET DISINTEGRATION;

CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DICLOFENAC; EXCIPIENTS; FATTY ACIDS; METHYLCELLULOSE; MODELS, CHEMICAL; PARTICLE SIZE; SOLUBILITY; TABLETS; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 3142757129     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120037487     Document Type: Article

References (14)

1. Inghelbrecht, S.; Remon, J.P. Roller compaction and tableting of microcrystalline cellulose/drug mixtures. Int. J. Pharm. 1998, 161, 215-224.
2. Miller, R.W. Advances in pharmaceutical roller compactor feed system designs. Pharm. Technol. 1994, 18 (3), 154-162.
3. Murray, M.; Laohavichien, A.; Habib, W.; Sakr, A. Effect of process variables on roller-compacted ibuprofen tablets. Pharm. Ind. 1998, 60 (3), 257-262.
4. Murray, M.; Sakr, A. Comparison of roller compacted and commercial ibuprofen tablets. Pharm. Res. 1996, 9 (13), S181 Suppl.
5. Li, L.C.; Peck, G.E. The effect of agglomeration methods on the micromeritic properties of a maltodextrin product, Maltrin 150T. Drug Dev. Ind. Pharm. 1990, 16 (9), 491-503.
6. Sheskey, P.J.; Cabelka, T.D.; Robb, R.T.; Boyce, B.M. Use of roller compaction in the preparation of controlled-release hydrophilic matrix tablets containing methylcellulose and hydroxypropyl methylcellulose polymers. Pharm. Technol. 1994, 18 (9), 132-150.
7. Sheskey, P.; Sackett, G.; Maher, L.; Lentz, K.; Tolle, S.; Polli, J. Roll compaction granulation of a controlled-release matrix tablet formulation containing HPMC. Pharm Technol. Tabletting and Granulation Yearbook. 1999, 6-21.
8. PDR Generics. Diclofenac Oral, 4th Ed.; Medical Economics Company: Montvale, NJ, 1998; 866-870.
9. Sheskey, P.J.; Dasbach, T.P. Evaluation of various polymers as dry binders in the preparation of an immediate-release tablet formulation by roller compaction. Pharm Technol. 1995, 19 (10), 98-112.
10. Sheskey, P.J.; Parsons, C.A.; Boyce, B.; Robb, R.; Caswell, O. Preparation of immediate-release niacinamide tablets by roller compaction using cellulose ether binders. Pharm. Res. 1993, 10 (10), S148 Suppl.
11. Obaidat, A.A.; Obaidat, R.M. Controlled release of tramadol hydrochloride from matrices prepared using glyceryl behenate. Eur. J. Pharm. Biopharm. September, 2001, 52 (2), 231-235.
12. Sheskey, P.J.; Hendren, J. The effects of roll compaction equipment variables, granulation technique, and HPMC polymer level on a controlled-release matrix model drug formulation. Pharm. Technol. 1999, 23 (3), 90-106.
13. Peppas, N.A. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 1985, 60, 110-115.
14. Myers, R.H.; Montgomery, D.C. Response Surface Methodology: Process and Product Optimization Using Designed Experiments; John Wiley & Sons: New York, NY, 1995.